Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1225-1228

  Ni, Zuyao ^a   Lou, Wei ^a   Leman, Eddy S ^a   Gao, Allen C ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; JANUS KINASE; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL DIFFERENTIATION; CONTROLLED STUDY; HOMEOBOX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; RATS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0034163461     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1999. CA Cancer J. Clin., 49: 8-31, 1999.
2. Gao, A. C., and Isaacs, J. T. Expression of homeobox gene-GBX2 in human prostatic cancer cells. Prostate, 29: 395-398, 1996.
3. Gao, A. C., Lou, W., and Isaacs, J. T. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity. Cancer Res., 58: 1391-1394, 1998.
4. Gao, A. C., Lou, W., and Isaacs, J. T. Enhanced GBX2 expression stimulates growth of human prostate cancer cells via transcriptional up-regulation of the interleukin-6 gene. Clin. Cancer Res., 6: 493-497, 2000.
5. Lou, W., Ni, Z. Y., Dyer, K., Tweardy, D. J., and Gao, A. C. Interleukin-6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway. Prostate, 42: 239-242, 2000.
6. Schinder, C., and Darnell, J. E., Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem., 64: 621-651, 1995.
7. Darnell, J. E., Jr. STATs and gene regulation. Science (Washington DC), 277: 1630-1635, 1997.
8. Watson, C. J., and Miller, W. R. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br. J. Cancer, 71: 840-844, 1995.
9. Gouilleux-Gruart, V., Gouilleux, F., Desaint, C., Claisse, J. F., Capiod, J. C., Delobel, J., Weber-Nordt, R., Dusanter-Fourt, I., Dreyfus, F., Groner, B., and Prin, L. Stat-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood, 87: 1692-1697, 1996.
10. Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., and Tweardy, D. J. Requirement of Stat3 but not Stal1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J. Clin. Investig., 102: 1385-1392, 1998.
11. Yu, C. L., Meyer, D. J., Campbell, G. S., Lamer, A. C., Carter-Su, C., Schwartz, J., and Jove, R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science (Washington DC), 269: 81-83, 1995.
12. Danial, N. N., Pernis, A., and Rothman, P. B. Jak-STAT signaling induced by the v-abl oncogene. Science (Washington DC), 269: 1875-1877, 1995.
13. Bromberg, J. F., Wrzeszczynska, M. H. Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., and Darnell, J. E., Jr. Stat3 as an oncogene. Cell, 98: 295-303, 1999.
14. Isaacs, J. T., Isaacs, W. B., Feitz, W. F. J., and Scheres, J. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostate cancers. Prostate, 9: 261-281, 1986.
15. Isaacs, J. T., and Hukku, B. Nonrandom involvement of chromosome 4 in the progression of rat prostatic cancer. Prostate, 13: 165-188, 1988.
16. Gao, A. C., Lou, W., Dong, J. T., and Isaacs, J. T. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res., 57: 846-849, 1997.
17. Gao, A. C., Lou, W., Ichikawa, T., Denmeade, S. R., Barrett, J. C., and Isaacs, J. T. Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1-13.2. Prostate, 38: 46-54, 1999.
18. Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., and Hirona, T. A central role for Stat3 in 1L-6 induced regulation of growth and differentiation in MI leukemia cells. EMBO J., 15: 3651-3658, 1996.
19. Kaptein, A., Paillard, V., and Saunders, M. Dominant negative Stat3 mutant inhibits interleukin-6 induced Jak-STAT signal transduction. J. Biol. Chem., 271: 5961-5964, 1996.
20. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, S. Freedman, M., Cohen, A., Gazit, A., Levitzki, A., and Roifman, C. M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature (Lond.), 379: 645-648, 1996.
21. Nielsen, M., Kaltoft, K., Nordahl, M., Ropke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A., and Odum, N. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc. Natl. Acad. Sci. USA, 94: 6764-6769, 1997.
22. Qiu, Y., Ravi, L., and Kung, H. J. Requirement of ErbB2 for signaling by interleukin-6 in prostate carcinoma cells. Nature (Lond.), 393: 83-85, 1998.
23. Yeh, S., Lin, H., Kang, H. Y., Thin, T. H., Lin, M. H., and Chang, C. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc. Natl. Acad. Sci. USA, 96: 5458-5463, 1999.
24. Craft, N., Shostak, Y., Carey, M., and Sawyers, C. L. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat. Med., 5: 280-285, 1999.
25. Abreu-Martin, M. T., Chari, A., Palladino, A. A., Craft, N. A., and Sawyers, C. L. Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer. Mol. Cell. Biol., 19: 5143-5154, 1999.
26. Chen, T., Cho, R. W., Stork, P. J., and Weber, M. J. Elevation of cyclic adenosine 3′, 5′-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells. Cancer Res., 59: 213-218, 1999.
27. McGinnis, W., and Krumlauf, R. Homeobox genes and axial patterning. Cell, 68: 283-302, 1992.
28. Ruddle, F. H., Bartels, J. L., Bentley, K. L., Kappen, C., Murtha, M. T. X., and Pendleton, J. W. Evolution of Hox genes. Annu. Rev. Genet., 28: 423-442, 1994.
29. Siegsmund, M. J., Yamazaki, H., and Pastan, I. Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia. J. Urol., 151: 1396-1399, 1994.
30. Twillie, D. A., Eisenberger, M. A., Carducci, M. A., Hseih, W. S., Kim, W. Y., and Simons, J. W. Interleukin-6: a candidate mediator of human prostate cancer morbidity. Urology, 45: 542-549, 1995.
31. Adler, H. L., McCurdy, M. A., Kattan, M. W., Timme, T. L., Scardino, P. T., and Thompson, T. C. Elevated levels of circulating interleukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma. J. Urol., 161: 182-187, 1999.